← back to search

Dan Su

University of Science and Technology of China · CN
Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, and Esophageal Cancer Research and Treatment.
h-index
39
citations
4,821
works
209
NIH funding
primary concept
email

Recent publications

Microbiota enterotoxigenic <i>Bacteroides fragilis</i>-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1
Protein & Cell 2024cited by 61position: middledoi
Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial
BMC Medicine 2024cited by 30position: middledoi
Tumour-associated macrophages and Schwann cells promote perineural invasion via paracrine loop in pancreatic ductal adenocarcinoma
British Journal of Cancer 2023cited by 55position: middledoi
Single‐cell third‐generation sequencing‐based multi‐omics uncovers gene expression changes governed by ecDNA and structural variants in cancer cells
Clinical and Translational Medicine 2023cited by 33position: middledoi
Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma
Modern Pathology 2023cited by 32position: middledoi
PDZ‐binding kinase aggravates pancreatic neuroendocrine neoplasm progression by activating the AKT/mTOR pathway
Molecular Carcinogenesis 2023cited by 2position: middledoi
circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway
Journal of Experimental & Clinical Cancer Research 2022cited by 94position: middledoi
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract
Cancer Communications 2022cited by 30position: middledoi
Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
Clinical Cancer Research 2021cited by 115position: middledoi
p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms
Gastroenterology Research and Practice 2021cited by 23position: middledoi
Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer
Frontiers in Oncology 2021cited by 17position: middledoi
Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis
Molecular Cancer 2020cited by 150position: middledoi
Development of a serum miRNA panel for detection of early stage non-small cell lung cancer
Proceedings of the National Academy of Sciences 2020cited by 84position: lastdoi
Tumor-neuroglia interaction promotes pancreatic cancer metastasis
Theranostics 2020cited by 76position: firstdoi
Tirofiban for acute ischemic stroke: systematic review and meta-analysis
European Journal of Clinical Pharmacology 2020cited by 48position: middledoi
Ubiquitin specific peptidase 5 enhances STAT3 signaling and promotes migration and invasion in Pancreatic Cancer
Journal of Cancer 2020cited by 29position: middledoi
Author Correction: Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma
Nature Communications 2020cited by 6position: middledoi
Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma
Nature Communications 2019cited by 149position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Quanbo Zhou · First Affiliated Hospital of Zhengzhou University4 papers (2020–2023)Leyi Huang · Zhejiang International Studies University3 papers (2020–2023)Huanwen Wu · University of Edinburgh2 papers (2021–2022) · 2 papers (2021–2022)Zhihua Li · Sun Yat-sen University2 papers (2020–2022)Zhiguo Li · University of Kentucky2 papers (2020–2023)Zhiyong Liang · Affiliated Hospital of Guizhou Medical University2 papers (2021–2022)Rufu Chen · Guangdong University of Technology2 papers (2020–2022)Longfa Lin · Sun Yat-sen University2 papers (2020–2023)Yue Ma · Harbin Medical University2 papers (2020–2024)Yueping Liu · Hebei Medical University2 papers (2021–2022)Yanqiao Zhang · Zhejiang Provincial People's Hospital2 papers (2020–2024)Hongcao Lin · Sun Yat-sen University1 papers (2022–2022)Xuefeng Xia · BGI Group (China)1 papers (2021–2021)Zhiqiang Fu · Harbin Engineering University1 papers (2020–2020)Yuanfei Yao · Harbin Medical University1 papers (2020–2020)Haitao Zhao · Shenyang Pharmaceutical University1 papers (2024–2024)Qichao Hu · Tianjin University1 papers (2023–2023)Dapeng Zhu · University of Shanghai for Science and Technology1 papers (2021–2021)Yuhua Gong · Peking University1 papers (2021–2021)